These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 25633786)
1. Market watch: Biopharma deal-making in 2014: a record year for M&A value. Micklus A; Muntner S Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786 [No Abstract] [Full Text] [Related]
2. Biotech jostles with pharma for slice of HIV market. Katsnelson A Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375 [No Abstract] [Full Text] [Related]
3. Deal watch: is deal-making becoming more difficult? Borshell N Nat Rev Drug Discov; 2011 Jun; 10(6):404. PubMed ID: 21629282 [No Abstract] [Full Text] [Related]
4. Biopharma deal-making in 2016. Micklus A; Muntner S Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988 [No Abstract] [Full Text] [Related]
5. Deal watch: recent trends in deal-making. Dawkes A; Papp T Nat Rev Drug Discov; 2010 Dec; 9(12):909. PubMed ID: 21119724 [No Abstract] [Full Text] [Related]
6. New IGF drug stirs competition in growth factor segment. Ratner M Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044 [No Abstract] [Full Text] [Related]
7. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development. Perakslis ED; Van Dam J; Szalma S Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001 [No Abstract] [Full Text] [Related]
8. Deal watch: Trends in discovery externalization. Mayhew S Nat Rev Drug Discov; 2010 Mar; 9(3):183. PubMed ID: 20190781 [No Abstract] [Full Text] [Related]
9. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science. Woosley RL; Myers RT; Goodsaid F Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457 [TBL] [Abstract][Full Text] [Related]
10. Precompetitive research: a new prescription for drug development? Woodcock J Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454 [No Abstract] [Full Text] [Related]
11. The biotech drug market. Lawrence S Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645 [No Abstract] [Full Text] [Related]
13. Precompetitive activity to address the biological data needs of drug discovery. Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293 [No Abstract] [Full Text] [Related]
14. Deal watch: Biopharma deal-making in 2015: changing the pharma landscape. Micklus A; Muntner S Nat Rev Drug Discov; 2016 Feb; 15(2):78-9. PubMed ID: 26837586 [No Abstract] [Full Text] [Related]
15. Biotech drug market steadily expands. Lawrence S Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279 [No Abstract] [Full Text] [Related]
16. Designs that enrich lives. Link A; Stark H Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676 [No Abstract] [Full Text] [Related]
17. Market watch: Upcoming catalysts in Q3 2014. Haggerty R Nat Rev Drug Discov; 2014 Jul; 13(7):486. PubMed ID: 24981351 [No Abstract] [Full Text] [Related]
18. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
19. Antisoma-Roche deal--a new kind of buyout? Mitchell P Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894 [No Abstract] [Full Text] [Related]